NCT01843660View on ClinicalTrials.gov

An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back Pain

PHASE4CompletedINTERVENTIONAL

Enrollment

1,059

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Low Back PainShoulder PainNeck Pain

Interventions

DRUG

Tramadol HCl-Paracetamol

Participants will receive 1 to 2 tablets of tramadol HCl-paracetamol orally once daily (each tablet containing tramadol 37.5 milligram \[mg\] and paracetamol 325mg) for up to a total duration of 6 hours. Additional dose may be given based upon the clinical requirement.

All Listed Sponsors

lead

Xian-Janssen Pharmaceutical Ltd.

INDUSTRY

NCT01843660 - An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back Pain | Biotech Hunter | Biotech Hunter